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Abstract
BACKGROUND—Early infant (1–60 days of life) male circumcision is being trialed in Africa as
a human immuno-deficiency virus prevention strategy. Postcircumcision bleeding is particularly
concerning where most infants are breastfed, and thus these infants are at increased risk of vitamin
K deficiency bleeding.
CASE—During a circumcision trial, one infant bled for 90 minutes postprocedure. After
discovering he had not received standard prophylactic vitamin K, we gave 2 mg phytomenadione
(vitamin K1) intramuscularly; bleeding stopped within 30 minutes.
CONCLUSION—Vitamin K’s extremely rapid action is not commonly appreciated. Neonatal
vitamin K has been shown to be cost-effective. To increase availability and promote awareness of
its importance, especially in low-resource settings where blood products and transfusions are
limited, vitamin K should be included in the World Health Organization’s Model List of Essential
Medicines for Children.
Male circumcision has been shown to reduce the risk of heterosexually-acquired human
immunodeficiency virus (HIV) infection in men, and male circumcision in early infancy
(defined as 1–60 days of life by the World Health Organization [WHO]) is recommended by
the WHO as part of HIV prevention strategies because of its relative ease and safety (http://
libdoc.who.int/publications/2007/9789241595988_eng.pdf) compared with the procedure in
older ages. Given the potential scale-up of early infant male circumcision in resource-limited
settings, more attention must be paid to the prevention and treatment of potential
postcircumcision bleeding associated with vitamin K deficiency. Those who perform
circumcision for religious or traditional reasons should also be aware of this potential cause
of postcircumcision bleeding.
Vitamin K deficiency bleeding can occur in infants up to 6 months of age, although it most
commonly occurs either in the first week of life (classical) or at 3–8 weeks (late). Infants are
at risk of vitamin K deficiency because they are born with low liver stores of vitamin K and
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subsequently may not be able to obtain sufficient amounts from breast milk. Before neonatal
vitamin K prophylaxis became the standard of care in the United States, vitamin K
deficiency bleeding had been reported after circumcisions done within the first week of life
at Cincinnati General Hospital, and bleeding in this population was most common among
the breastfed neonates.1 Postcircumcision bleeding is of particular concern in the developing
world where the majority of infants are breastfed and thus at increased risk of vitamin K
deficiency bleeding.
In a recent report from Kenya, one of the reasons given by parents for not wanting to
circumcise an infant was fear of bleeding2 and in a recent trial of circumcision in Zambia,
most of the adverse events were excessive bleeding with one case requiring a transfusion.3
Therefore, the use of vitamin K to prevent or treat postcircumcision bleeding deserves
urgent attention as countries in sub-Saharan Africa are poised to scale-up early infant male
circumcision as part of HIV-prevention interventions.
CASE
We report a case of probable vitamin K deficiency bleeding that occurred during a clinical
trial of infant circumcision in Botswana (registered at www.clinical-trials.gov as
NCT00971958), a country in which postpartum vitamin K prophylaxis is routine. All
circumcisions were performed by a medical doctor using the AccuCirc device either within
the maternity ward or in a clinic adjacent to the main hospital. Among 150 newborns
circumcised between 1 and 10 days of life, five instances of minor localized bleeding
occurred and were successfully managed by up to 20 minutes of local pressure. A sixth
newborn (estimated gestational age 39 weeks, birth weight 4.1 kilos, day two of life),
however, began to bleed approximately 2 hours after circumcision and continued to bleed
for more than 90 minutes despite application of local pressure. No localized, single source
for the bleeding could be identified. After discovering that this newborn had not received
standard vitamin K prophylaxis, we administered 2 mg phytomenadione (vitamin K1) intra-
muscularly and bleeding stopped within 30 minutes.
COMMENTS
The extremely rapid action of vitamin K seen in this case is not commonly appreciated but is
consistent with a report of four vitamin K deficiency bleeding cases in which intravenous
vitamin K substantially corrected grossly prolonged prothrombin times and reduced
bleeding as early as 20 minutes after injection.4 This is important information in low-
resource settings where blood products and transfusions may not be readily available.
The evidence for the administration of prophylactic vitamin K immediately after birth to
prevent bleeding is well established and it is routinely provided to infants in developed
countries.5 Although the administration of vitamin K in low-resource settings is less well
established and many health care providers are not aware of its importance, a study from
Vietnam of intracranial hemorrhage and its sequelae suggests that vitamin K prophylaxis is a
highly cost-effective intervention.6
Without vitamin K prophylaxis, the incidence of vitamin K deficiency bleeding may range
from 0.25% to 1.7%. Manifestations can include intracranial hemorrhage6 and bleeding
from the gastrointestinal tract, nose, and after circumcision.4 High mortality among
hospitalized cases has been noted4 with lack of resources and treatment delay being
contributing factors. Importantly, a recent Ugandan study showed that 65% of newborns had
an elevated PIVKA-II, a marker of vitamin K insufficiency,4 with 22% of values predictive
of abnormal hemostasis (S. Data et al, personal communication).
Plank et al. Page 2













We are not aware of any systematic review of the use of vitamin K in Africa, so we gathered
information from colleagues in 10 of the 14 WHO priority countries for scale-up of male
circumcision: Botswana, Kenya, Malawi, Mozambique, Rwanda, South Africa, Tanzania,
Uganda, Zambia, and Zimbabwe. Despite the known efficacy of vitamin K, we found that
policies and implementation of vitamin K administration to newborns vary significantly.
Colleagues in 6 of 10 countries reported that there was a policy for routine administration at
birth, and some specified that intramuscular administration was used. In the countries where
a policy is in place, vitamin K is usually only available for hospital births, and stockouts
may occur; actual coverage is generally not known and gathering this information is not part
of an established evaluation scheme. In three of the four countries where a policy for routine
use is not in place or is not well publicized, colleagues reported that vitamin K is only given
to premature neonates, neonates admitted to neonatal high-risk wards or intensive care
nurseries, or both.
Although a recent health facilities survey in Uganda included vitamin K in its list of
essential medicines, and vitamin K is recommended in the WHO 2005 Pocket Book of
Hospital Care for Children as standard of care for all newborns (http://whqlibdoc.who.int/
publications/2005/9241546700.pdf), vitamin K is not included in the WHO 2011 Model List
of Essential Medicines for Children (http://whqlibdoc.who.int/hq/2011/a95054_eng.pdf) nor
in the United Nations Children’s Fund supply catalog (https://supply.unicef.org/, retrieved
October 3, 2012).
Health care providers in resource-limited settings should be aware of the dangers of vitamin
K deficiency bleeding, the known efficacy of vitamin K prophylaxis, and, as demonstrated
in our case, the rapid action of vitamin K for treating incident cases. For prophylaxis in
Africa, researchers could consider the feasibility of adding an oral vitamin K formulation to
safe birthing kits for out-of-hospital births, similar to the use of oral prostaglandins to
prevent postpartum hemorrhage,7 or to evaluating single-dose, prefilled, disposable devices
such as the ones being considered for administration of vaccines.8
As early infant male circumcision is scaled-up in Africa as part of HIV prevention programs,
increased vigilance will be essential to prevent deaths from vitamin K deficiency bleeding.
If postcircumcision bleeding is not prevented and addressed, it may negatively affect
programmatic scale-up of infant circumcision for HIV prevention.2,3 Ideally, the WHO, the
United Nations Children’s Fund, and donor agencies should collaborate to promote broader
awareness of the importance of vitamin K and facilitate its availability.
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